BRKR(Bruker Corporation) · 财务报表

BRKR(Bruker Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$2.42B$2.53B$2.96B$3.37B$3.44B
毛利润$1.21B$1.31B$1.51B$1.65B$1.58B
营业利润$413.30M$432.70M$436.90M$253.10M$68.20M
净利润$277.10M$296.60M$427.20M$113.10M−$8.60M
经营现金流$282.40M$274.40M$350.10M$251.30M$134.10M
自由现金流$190.40M$145.20M$243.20M$136.00M$43.30M
摊薄每股收益$1.81$1.99$2.90$0.76$-0.15

Bruker Corporation BRKR